市場調查報告書
商品編碼
1291616
靜脈治療和靜脈通路市場2023-2028年按類型、應用、終端用戶和地區分類Intravenous Therapy and Vein Access Market by Type, Applications, End User, and Region 2023-2028 |
2022年,全球靜脈(IV)治療和靜脈通路市場規模達到238.5億美元。展望未來,IMARC Group預計,到2028年,市場規模將達到328.3億美元,在2023-2028年期間呈現5.31%的成長率(CAGR)。慢性病的日益流行,道路事故的不斷增加,以及消費者對靜脈治療的好處的認識不斷提高,是推動市場發展的一些關鍵因素。
靜脈治療是一種醫療程序,包括通過靜脈將液體、藥物和營養直接注入血液中。這種技術通常用於醫院、診所和其他醫療機構,以治療各種病症和疾病。靜脈通路是進入靜脈的過程,以便進行靜脈治療。醫護人員通常使用針頭穿刺皮膚並進入靜脈,由於靜脈小或受損、脫水和肥胖等因素,這對一些病人來說可能是個挑戰。靜脈治療有幾種類型,包括治療脫水的鹽水、治療感染的抗生素和治療癌症的化療。除了治療疾病,靜脈治療還可用於預防措施,如接受疫苗接種和維生素。
癌症、糖尿病和自身免疫性疾病等需要長期用藥和監測的慢性病和生活方式疾病的發病率越來越高,這主要推動了全球靜脈(IV)治療和靜脈通路市場的成長。除此之外,道路事故發生率的上升和外傷病例的激增也促進了市場的成長。此外,消費者對靜脈治療和靜脈通路好處的認識不斷提高,以及重症監護治療的增加,都為市場提供了有利的成長機會。與此相呼應,對微創手術的偏愛正在成為另一個重要的成長誘導因素。除此之外,醫療行業的許多技術進步,以減少所需的時間和精力,降低感染的風險,並提高手術的準確性,正在為市場創造一個積極的前景。同時,為創新新療法、藥物和設備而進行的廣泛的研究和開發(R&D)活動投資正在幫助市場擴張。此外,醫療支出的增加,醫院數量的增加,家庭醫療的廣泛採用,以及老年人口的擴大,正在加強市場的成長。
請注意,這只代表部分公司的名單,完整的名單已在報告中提供。
The global intravenous (IV) therapy and vein access market size reached US$ 23.85 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 32.83 Billion by 2028, exhibiting a growth rate (CAGR) of 5.31% during 2023-2028. The growing prevalence of chronic diseases, the increasing incidences of road accidents, and the rising consumer awareness about the benefits of IV therapy represent some of the key factors driving the market.
Intravenous (IV) therapy is a medical procedure that involves administering fluids, medications, and nutrition directly into the bloodstream through a vein. This technique is commonly used in hospitals, clinics, and other healthcare facilities to treat various conditions and illnesses. Vein access is the process of entering a vein in order to administer IV therapy. A healthcare professional typically uses a needle to puncture the skin and access a vein, which can be challenging in some patients due to factors such as small or damaged veins, dehydration, and obesity. There are several types of IV therapy, including saline solutions for dehydration, antibiotics for infections, and chemotherapy for cancer treatment. In addition to treating medical conditions, IV therapy can also be used for preventative measures, such as receiving vaccinations and vitamins.
The increasing prevalence of chronic and lifestyle diseases, such as cancer, diabetes, and autoimmune diseases that require long-term medication and monitoring, is primarily driving the global intravenous (IV) therapy and vein access market growth. Besides this, the rising incidences of road accidents and the surging number of trauma cases are contributing to the market growth. Moreover, the escalating consumer awareness about the benefits of IV therapy and vein access and the rise in critical care therapies are presenting remunerative growth opportunities for the market. In line with this, the shifting preference for minimally invasive procedures is acting as another significant growth-inducing factor. In addition to this, numerous technological advancements in the healthcare industry to reduce the needed time and effort, lower the risk of infection, and improve the accuracy of the procedure are creating a positive outlook for the market. Concurrent with this, extensive investments in research and development (R&D) activities for innovating new therapies, drugs, and devices are aiding in market expansion. Furthermore, the increasing healthcare expenditure, rise in the number of hospitals, the widespread adoption of home healthcare, and the expanding geriatric population are strengthening the market growth.
IMARC Group provides an analysis of the key trends in each segment of the global intravenous (IV) therapy and vein access market, along with forecasts at the global, regional, and country levels from 2023-2028. Our report has categorized the market based on type, application, and end user.
The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the type. This includes implantable ports, intravenous catheters, hypodermic needles, infusion pumps, and others. According to the report, intravenous catheters represented the largest segment.
A detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the application has also been provided in the report. This includes nutrition and buffer solution, volume expander, medication administration, and blood-based products. According to the report, medication administration accounted for the largest market share.
The report has provided a detailed breakup and analysis of the intravenous (IV) therapy and vein access market based on the end user. This includes hospitals, ambulatory surgical centers, and clinics. According to the report, hospitals represented the largest segment.
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for intravenous (IV) therapy and vein access. Some of the factors driving the North America intravenous (IV) therapy and vein access market included the growing prevalence of chronic diseases, the increasing number of road accidents, and the expanding geriatric population.
The report has also provided a comprehensive analysis of the competitive landscape in the global intravenous (IV) therapy and vein access market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AngioDynamics Inc., B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Cardinal Health Inc., Fresenius SE & Co. KGaA, ICU Medical Inc., Medtronic plc, Tekni-Plex Inc., Teleflex Incorporated, Terumo Corporation, Vygon SAS, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.